GAMIFANT

emapalumab-lzsg · Swedish Orphan Biovitrum AB (publ)

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for GAMIFANT, covering 2018-11-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Targeting Interferon Gamma With Emapalumab to Lung Transplant Recipients With Interferon Gamma-high Acute Lung Allograft Dysfunction [Phase 2]

See pricing